[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100603116":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":13,"locations":19,"responsibleParty":36,"collaborators":38,"id":45,"slug":7,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":46,"sex":52,"minAge":53,"maxAge":7,"enrollmentInfo":54,"targetDuration":57,"studyType":58,"phases":7,"briefSummary":48,"conditions":59,"keywords":64,"overallStatus":22,"whyStopped":7,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"University Hospital Tuebingen","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"BIOLOGICAL","Biologic Agent","Intervention with biologic agents",[14],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Nisar P Malek, Prof. Dr.","CONTACT","+4970712982722","zpm-meb@med.uni-tuebingen.de",[20],{"facility":21,"status":22,"city":23,"state":7,"zip":24,"country":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"University Hospital of Tübingen - Center for Personalized Medicine","RECRUITING","Tübingen","72076","Germany",{"type":27,"coordinates":28},"Point",[29,30],9.05222,48.52266,{"lat":30,"lon":29},[33],{"name":34,"role":16,"phone":35,"phoneExt":7,"email":18},"Fee Schmitt, Dr.","+4970712981240",{"type":37,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[39,41,43],{"name":40,"class":6},"University Hospital Freiburg",{"name":42,"class":6},"University Hospital Heidelberg",{"name":44,"class":6},"University Hospital Ulm","100603116",false,"NCT07132333","Molecular Inflammation Board at the Center for Personalized Medicine","The Molecular Inflammation Board at the Centers for Personalized Medicine at the University Hospitals of Freiburg, Heidelberg, Tübingen and Ulm - A Multicenter Prospective Observational Study","MEB@ZPM","Inclusion Criteria:\n\n* Chronic inflammatory disorder (PsO, PsA, SpA, IBD)\n* Given informed consent\n* 18 years of age\n\nExclusion Criteria:\n\n* No capacity to consent","ALL","18 Years",{"count":55,"type":56},3000,"ESTIMATED","14 Months","OBSERVATIONAL",[60,61,62,63],"Psoriasis (PsO)","Psoriasis Arthritis","Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)","Spondylarthropathies",[65,66],"chronic inflammatory diseases","personalized medicine","2025-08-19",{"date":69,"type":70},"2025-08-20","ACTUAL",{"date":72,"type":70},"2022-11-16",{"date":74,"type":56},"2032-11",{"name":5,"class":6},1]